Seroatlas · Human Serome Atlas

ST3GAL1

CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1

Also known as: SIA4A_HUMAN, SIAT4A, SIATFL, ST3GalA.1, ST3O

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q11201
Gene
ST3GAL1
Ensembl
ENSG00000008513
Chromosome
8
Canonical length
340 aa
Protein class
Enzymes, Metabolic proteins, Predicted intracellular proteins
Secretome location
Intracellular and membrane

OverviewNCBI Gene

The protein encoded by this gene is a type II membrane protein that catalyzes the transfer of sialic acid from CMP-sialic acid to galactose-containing substrates. The encoded protein is normally found in the Golgi but can be proteolytically processed to a soluble form. Correct glycosylation of the encoded protein may be critical to its sialyltransferase activity. This protein, which is a member of glycosyltransferase family 29, can use the same acceptor substrates as does sialyltransferase 4B. Two transcript variants encoding the same protein have been found for this gene. Other transcript variants may exist, but have not been fully characterized yet. [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

340 residues, UniProt reviewed canonical sequence.

>Q11201|ST3GAL1
     1  MVTLRKRTLK VLTFLVLFIF LTSFFLNYSH TMVATTWFPK QMVLELSENL KRLIKHRPCT
    61  CTHCIGQRKL SAWFDERFNQ TMQPLLTAQN ALLEDDTYRW WLRLQREKKP NNLNDTIKEL
   121  FRVVPGNVDP MLEKRSVGCR RCAVVGNSGN LRESSYGPEI DSHDFVLRMN KAPTAGFEAD
   181  VGTKTTHHLV YPESFRELGD NVSMILVPFK TIDLEWVVSA ITTGTISHTY IPVPAKIRVK
   241  QDKILIYHPA FIKYVFDNWL QGHGRYPSTG ILSVIFSMHV CDEVDLYGFG ADSKGNWHHY
   301  WENNPSAGAF RKTGVHDADF ESNVTATLAS INKIRIFKGR

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against ST3GAL1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Secreted
Secreted
Yes
Transmembrane segments
1
Mean surface accessibility (rSASA)
0.28
Highest tissue expression
63 nTPM

Expression across tissuesHPA

Tissue

  • liver: 63 nTPM
  • thyroid gland: 62 nTPM
  • heart muscle: 50 nTPM
  • tongue: 46 nTPM
  • skeletal muscle: 42 nTPM
  • kidney: 42 nTPM

Single-cell type

  • innate lymphoid cells: 363 nCPM
  • neutrophils: 311 nCPM
  • myonuclei: 307 nCPM
  • cardiomyocytes: 294 nCPM
  • thymocytes: 257 nCPM
  • monocytes: 250 nCPM

Immune cell

  • basophil: 48 nTPM
  • NK-cell: 43 nTPM
  • eosinophil: 42 nTPM
  • naive B-cell: 39 nTPM
  • naive CD4 T-cell: 35 nTPM
  • naive CD8 T-cell: 33 nTPM

Brain region

  • choroid plexus: 26 nTPM
  • midbrain: 25 nTPM
  • cerebral cortex: 20 nTPM
  • amygdala: 19 nTPM
  • medulla oblongata: 17 nTPM
  • hippocampal formation: 16 nTPM

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.5
gnomAD pLI
0.58
gnomAD missense Z
1.3
DepMap mean gene effect
-0.24
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of ST3GAL1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads ST3GAL1 as an antibody target. Whether an autoantibody or antibody against ST3GAL1 could matter depends on whether native ST3GAL1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

ST3GAL1 is annotated as secreted, so native ST3GAL1 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.

Annotation status

The present source text does not explicitly label ST3GAL1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/ST3GAL1. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...